Moreover, the few leukocytes that were produced by Rpl22-deficient HSCs were profoundly biased toward the myeloid fate (CD11b+Gr1+; Figure 3B), consistent with the basal myeloid-bias observed in the donor Rpl22−/− mice and in patients with MDS.39 This evidence concerns the gene RPL22 and myelodysplastic syndrome.